Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
Jounce Therapeutics, Inc.
The company gets a regulatory nod that will put $25 million in its pocket.
These baby biotechs are itching to come out of their shells.
No podcast episodes available.
JNCE earnings call for the period ending September 30, 2021.
JNCE earnings call for the period ending June 30, 2021.
JNCE earnings call for the period ending March 31, 2021.
JNCE earnings call for the period ending February 25, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.